The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 09, 2006
Filed:
Mar. 12, 1997
Luis Enjuanes Sanchez, Madrid, ES;
Juan Plana Duran, Vall de Bianya-Olot, ES;
Sara Alonso Villanueva, Bilbao, ES;
Maluisa Ballesteros Jarreno, Cuenca, ES;
Joaquin Castilla Castrillon, Madrid, ES;
José Manuel Gonzalez Martinez, Murcia, ES;
Ander Izeta Parmesan, Guipúzcoa, ES;
Ana Mendez Zunzunegui, Pontevedra, ES;
Maria Muntion Saenz, Pamplona Navarra, ES;
Zoltán Penzes, Madrid, ES;
José Manuel Sanchez Morgado, Madrid, ES;
Carlos Miguel Sanchez Sanchez, Madrid, ES;
Cristina Smerdou Picazo, Madrid, ES;
Isabel Sola Gurpegui, Navarra, ES;
Luis Enjuanes Sanchez, Madrid, ES;
Juan Plana Duran, Vall de Bianya-Olot, ES;
Sara Alonso Villanueva, Bilbao, ES;
MaLuisa Ballesteros Jarreno, Cuenca, ES;
Joaquin Castilla Castrillon, Madrid, ES;
José Manuel Gonzalez Martinez, Murcia, ES;
Ander Izeta Parmesan, Guipúzcoa, ES;
Ana Mendez Zunzunegui, Pontevedra, ES;
Maria Muntion Saenz, Pamplona Navarra, ES;
Zoltán Penzes, Madrid, ES;
José Manuel Sanchez Morgado, Madrid, ES;
Carlos Miguel Sanchez Sanchez, Madrid, ES;
Cristina Smerdou Picazo, Madrid, ES;
Isabel Sola Gurpegui, Navarra, ES;
Cyanamid Iberica, S.A., Madrid, ES;
Abstract
The vectors comprise a recombinant defective viral genome expressing at least one antigen suitable for the induction of systemic and secretory immune responses or an antibody conferring protection against an infectious agent. The defective viral genome comprises the genome of a parental virus having the viral replicase recognition signals located on ends 3' and 5′, further comprising internal deletions, and wherein said defective viral genome depends on a helper virus for its replication and encapsidation. These vectors are suitable for the forming of a recombinant system comprising the aforesaid expression vector, and a helper virus. The system is suitable for the manufacture of mono- and polyvalent vaccines against infectious agents of different animal species, especially pigs, dogs and cats, and as expression vehicles for antibodies protective against infectious agents.